Company Overview and News

 
Wabtec: Long-Term Value Creator Continues To Struggle

2018-02-22 seekingalpha
Going back in time to 2015, and factoring in the impact of the Faiveley transaction and bolt-on deals, the company's performance is disappointing.
Upvote Downvote

 
Westinghouse Air Brake Is Too Expensive

2018-02-02 seekingalpha
Although there's some merit in the idea that you should buy shares of companies that are beneficiaries of CAPEX, it doesn't always work out.
Upvote Downvote

 
Earnings Review and Free Research Report: Westinghouse Air Brake Technologies’ Revenue surged 42%; Latest Acquisition Being a Hit

2017-11-07 accesswire
LONDON, UK / ACCESSWIRE / November 7, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Westinghouse Air Brake Technologies Corp. (NYSE: WAB) ("Wabtec"), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=WAB, following the Company's posting of its financial results on October 24, 2017, for the third quarter fiscal 2017 (Q3 FY17). The results of the leading provider of systems, equipment for transit and freight rail, exceeded Wall Street's expectations.
Upvote Downvote

 
Westinghouse Air Brake Technologies Corp Rides Its Latest Acquisition to Higher Revenue

2017-07-25 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Here's Why Westinghouse Air Brake Technologies Corp.'s Stock Is Slumping Today

2017-07-25 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Acquisitions Drive Westinghouse Air Brake Technologies Corp's Revenue Higher

2017-04-25 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Westinghouse Air Brake shares could rise 20 pct in a year -Barron's

2017-04-17 reuters
April 16 Shares of railroad equipment provider Westinghouse Air Brake Technologies Corp could rise as much as 20 percent as robust growth in the global mass-transit market offsets a recent slump in freight volumes, Barron's said.
Upvote Downvote

 
Railroads Stocks on Investors' Radar -- CSX Corp., Union Pacific, Canadian Pacific, and Westinghouse Air Brake

2017-04-05 prnewswire
Stock-Callers.com today shifts investors' focus on the Railroads industry which is engaged in hauling freight. Rail operators enable the efficient flow of goods from producers to consumers, and are therefore a vital part of the broad economy. Lined up for review this morning are: CSX Corp. (NASDAQ: CSX), Union Pacific Corp. (NYSE: UNP), Canadian Pacific Railway Ltd (NYSE: CP), and Westinghouse Air Brake Technologies Corp.
Upvote Downvote

 
Focus On Europe: Who Earned A $250M Performance Bonus Last Week?

2017-03-27 seekingalpha
You're out of luck if you booked a trip from Chicago or Miami on Finnair this summer.
Upvote Downvote

 
Westinghouse Air Brake Technologies (WAB) Q4 2016 Results - Earnings Call Transcript

2017-02-21 seekingalpha
Good day and welcome to the Wabtec Fourth Quarter 2016 Earnings Conference Call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded.
Upvote Downvote

 
Acquisition Costs and Weak Market Conditions Weigh on Westinghouse Air Brake Technologies Corp's Results

2017-02-21 fool
Last year was full of challenges for Westinghouse Air Brake Technologies (NYSE:WAB), or Wabtec. Not only was the rail industry under pressure due to slowing global trade, but it has taken the company longer than expected to close its acquisition of Faiveley Transport. Those issues clearly weighed on the company's fourth quarter results. However, some of those challenges are now in the rearview mirror, which gives the company confidence that 2017 will be a better year.
Upvote Downvote

 
Global Leader Of Highly Engineered Components In Stable Industry With Favorable Secular Trends

2017-01-23 seekingalpha
Onaverage, over the last several years, more than 60% of Wabtec’s total saleshave come from the aftermarket products and services business.
Upvote Downvote

 
Appointment of Non-Executive Director

2017-01-10 londonstockexchange
Cairn is pleased to announce the appointment of Nicoletta Giadrossi as an independent non-executive director with effect from 10 January 2017.
Upvote Downvote

 
How These Railroads Stocks are Faring? -- Westinghouse Air Brake Technologies, Canadian Pacific Railway, Greenbrier, and Genesee & Wyoming

2016-12-19 prnewswire
Companies in the Railroads segment operate railroad tracks and/or trains that generally transport cargo or passengers many times over great distances. They are generally stable and established, and offer lower-than-average dividend yields. Ahead of today's trading session, Stock-Callers.com reviews the performances of the following stocks: Westinghouse Air Brake Technologies Corp. (NYSE: WAB), Canadian Pacific Railway Ltd (NYSE: CP), The Greenbrier Cos.
Upvote Downvote

 
Wabtec Is Fully Valued After Recent Momentum Run, And Making Progress On Faiveley

2016-12-06 seekingalpha
The excellent positioning and long term value creation make shares an appealing long term investment, yet after the recent run higher I am not a buyer at these levels.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...